# Levothyroxine Sodium

NDC: 51655-705
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210430

FDA application: NDA021210

## Active ingredients

- LEVOTHYROXINE SODIUM: .088 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-705"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-705
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c968836a-f94c-4d13-e053-2995a90a8df5